5-hydroxytryptamine receptor 3A (5-HT3A) (5-HT3A)

The 5-hydroxytryptamine receptor 3A (5-HT3A) is a member of the Cys-loop family of ligand-gated ion channels and represents the only ionotropic serotonin receptor (UniProt: P46098). Unlike other serotonin receptors that are G protein-coupled, the 5-HT3A receptor functions as a non-selective cation channel that mediates fast excitatory neurotransmission in both the central and peripheral nervous systems (PubMed: 25160501). It is primarily located on terminals of the vagus nerve and within the area postrema of the brainstem, where it plays a critical role in the integration of the emetic reflex (StatPearls: NBK554413). In the gastrointestinal tract, these receptors regulate visceral perception and intestinal motility, making them significant targets for treating irritable bowel syndrome (PubMed: 17350074). Pharmacological modulation typically involves the use of "setron" class antagonists, which are gold-standard treatments for chemotherapy-induced and postoperative nausea and vomiting (PubChem: CID 5284564). Beyond emesis, the receptor is implicated in psychiatric conditions such as anxiety and schizophrenia, though therapeutic applications in these areas remain a subject of ongoing research (NIH: PMC3071730). Safety considerations for 5-HT3A antagonists include potential cardiovascular effects like QT prolongation and gastrointestinal issues such as severe constipation (FDA: Drug Safety Communication 2012).

Other names

HTR3ASerotonin receptor 3A5-hydroxytryptamine receptor 3 subunit A5-HT3R

Competitive antagonism of the 5-HT3 receptor, which inhibits the opening of the non-selective cation channel, thereby preventing serotonin-mediated depolarization of vagal afferents and central neurons (StatPearls: NBK554413).